You can still find attractive stocks despite all of the turbulence. Many stocks have been losers in 2025 amid the market chaos, but not Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Shares of Warren ...

Vertex AI souped up, Ironwood TPU, agent SDK and Cloud WAN for companies: These are just some of the highlights from the ...

Zacks Research bumped up Vertex Pharmaceuticals’ Q1 2027 earnings forecast by a thrilling one cent, now expecting $4.24 per ...

Vertex Minerals Ltd. is pleased to announce that the Company's engineering and geology team at the Reward Mine have identified an additional two stope block that have not been previously reported.

Learn more about whether Bitdeer Technologies Group or Vertex, Inc. is a better investment based on AAII's A+ Investor grades ...

We expect investors to focus on the sales numbers of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other ...

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $492.47, moving +0.01% from the previous trading session. This move lagged the S&P 500's daily gain of 2.03%. Elsewhere, the Dow ...

The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

Vertex Pharmaceuticals got a healthy boost on Tuesday, with shares climbing nearly 3% thanks to a double dose of analyst ...

Vertex Pharmaceuticals ( VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech 's shares closed the day nearly 3% ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.